Targeting Abnormal Cell Metabolism Shows Promise for Treating Aggressive Pediatric Brain Tumors
Dana-Farber Researchers Present Key Studies at ASCO Annual Meeting
Immunotherapy Combination Shows Benefit for Patients with Advanced Melanoma, Phase 3 Trial Shows
Anti-HER2 Treatments Can Cause Pulmonary Toxicities in HER2+ Breast Cancer
Proton Therapy Radiation Benefits Woman with Rhabdomyosarcoma, a Tumor Rarely Found in Adults
Targeted Agent Shows Early Promise Against a Dangerous Infant Leukemia
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA
Looking for Cancer’s Achilles Heel: The Pediatric Cancer Dependency Map
Proton Therapy Provides Successful Re-IrradiationA More Precise, Effective Option for Treatment of Recurrent Squamous Cell Carcinoma of the Lung
A More Precise, Effective Option for Treatment of Recurrent Squamous Cell Carcinoma of the Lung
Liver and Biliary Cancer Surgery Program Offers Multidisciplinary Care, Advanced Treatments
Father of Five and Military Veteran Wins Battle Over Throat Cancer
Researchers Focus on How to Invigorate ‘Exhausted’ T-Cells in Immunotherapy
Proton Therapy Hypofractionation for Prostate CancerAn effective option that reduces the length of radiation treatment in a young patient with early-stage prostate cancer
An effective option that reduces the length of radiation treatment in a young patient with early-stage prostate cancer
mRNA Takes Center Stage in COVID-19 Vaccine and Cancer Research
Dana-Farber Cancer Institute Faculty Recognized as 2021 ASCO Leaders in Cancer Care
Showing 616 - 630 of 1055 results
Previous| 1... 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 ...71 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
